[HTML][HTML] Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

PC Schuberth, C Hagedorn, SM Jensen… - Journal of translational …, 2013 - Springer
Introduction Malignant pleural mesothelioma (MPM) is an incurable malignant disease,
which results from chronic exposition to asbestos in at least 70% of the cases. Fibroblast …

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

PC Schuberth, C Hagedorn, SM Jensen… - Journal of …, 2013 - hero.epa.gov
INTRODUCTION: Malignant pleural mesothelioma (MPM) is an incurable malignant
disease, which results from chronic exposition to asbestos in at least 70% of the cases …

[HTML][HTML] Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

PC Schuberth, C Hagedorn, SM Jensen… - Journal of …, 2013 - ncbi.nlm.nih.gov
Methods To evaluate FAP expression immunohistochemistry was performed in tumor tissue
from MPM patients. CD8+ human T cells were retrovirally transduced with an anti-FAP-F19-∆ …

[PDF][PDF] Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

PC Schuberth, C Hagedorn, SM Jensen, P Gulati… - 2013 - cyberleninka.org
Introduction: Malignant pleural mesothelioma (MPM) is an incurable malignant disease,
which results from chronic exposition to asbestos in at least 70% of the cases. Fibroblast …

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

PC Schuberth, C Hagedorn… - Journal of …, 2013 - providence.elsevierpure.com
Introduction: Malignant pleural mesothelioma (MPM) is an incurable malignant disease,
which results from chronic exposition to asbestos in at least 70% of the cases. Fibroblast …

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells.

PC Schuberth, C Hagedorn, SM Jensen… - Journal of …, 2013 - europepmc.org
Methods To evaluate FAP expression immunohistochemistry was performed in tumor tissue
from MPM patients. CD8+ human T cells were retrovirally transduced with an anti-FAP-F19-∆ …

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells.

PC Schuberth, C Hagedorn, SM Jensen… - Journal of translational …, 2013 - sonar.ch
METHODS To evaluate FAP expression immunohistochemistry was performed in tumor
tissue from MPM patients. CD8+ human T cells were retrovirally transduced with an anti-FAP …

Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

PC Schuberth, C Hagedorn, SM Jensen… - Journal of Translational …, 2013 - zora.uzh.ch
INTRODUCTION: Malignant pleural mesothelioma (MPM) is an incurable malignant
disease, which results from chronic exposition to asbestos in at least 70% of the cases …

[PDF][PDF] Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

PC Schuberth, C Hagedorn, SM Jensen, P Gulati… - 2013 - researchgate.net
Introduction: Malignant pleural mesothelioma (MPM) is an incurable malignant disease,
which results from chronic exposition to asbestos in at least 70% of the cases. Fibroblast …

[PDF][PDF] Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells

PC Schuberth, C Hagedorn, SM Jensen, P Gulati… - 2013 - core.ac.uk
Introduction: Malignant pleural mesothelioma (MPM) is an incurable malignant disease,
which results from chronic exposition to asbestos in at least 70% of the cases. Fibroblast …